E
Elicio Therapeutics, Inc. (ELTX)
NCM – Real Time Price. Currency in USD
10.55
-1.06 (-9.13%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
10.55
-1.06 (-9.13%)
At close: May 12, 2026, 4:00 PM EDT
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
| Name | Position |
|---|---|
| Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D. | Founder & Independent Director |
| Dr. Christopher M. Haqq M.D., Ph.D. | Executive VP, Head of Research & Development and Chief Medical Officer |
| Dr. Darrell J. Irvine Ph.D. | Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board |
| Dr. Peter DeMuth Ph.D. | Chief Scientific Officer |
| Dr. Preetam Shah M.B.A., Ph.D. | Chief Strategy & Financial Officer and Treasurer |
| Mr. Marc J. Wolfgang M.S. | Chief Technology Officer |
| Mr. Robert T. Connelly | CEO, President & Director |
| Ms. Esther Welkowsky | Senior Vice President of Clinical Development |
| Ms. Joy Seymour | VP & Head of Regulatory Affairs |
| Ms. Megan C. Filoon | General Counsel, Secretary & Compliance Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | 10-K/A | angn-20251231.htm |
| 2026-03-16 | 8-K | angn-20260316.htm |
| 2026-03-12 | S-8 | elicios-8march2026.htm |
| 2026-03-12 | S-3/A | elicio-sx3a2.htm |
| 2026-03-02 | S-3/A | elicio-shelfsx3a.htm |
| 2026-02-27 | S-3 | elicio-shelfsx3.htm |
| 2025-12-01 | CORRESP | filename1.htm |
| 2025-11-13 | S-3 | elicio-resalesx3.htm |
| 2025-09-17 | 8-K | d38971d8k.htm |
| 2025-08-12 | 8-K | angn-20250812.htm |